Aeterna Zentaris Inc.

-0.07 (-1.91%)
4:35:02 PM EDT: $3.70 +0.01 (+0.14%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)17.94M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1.1 Million
Adjusted EPS-$0.93
See more estimates
10-Day MA$3.79
50-Day MA$3.83
200-Day MA$5.56
See more pivots

Aeterna Zentaris Inc. Stock, NASDAQ:AEZS

222 Bay Street, Suite 3000, Toronto, Ontario M5K 1E7
Phone: +1 418 652-8525
Number of Employees: 17


?†terna Zentaris, Inc. operates as a specialty biopharmaceutical company, which engages in the development of therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.